Compositions for drug delivery
View Patent ↗Substantially non-porous polymeric microparticles comprising a hydrophobic polymer and a plasticizer, and containing therein a bioactive or bioinactive agent.
1. Substantially non-porous polymeric microparticles comprising a hydrophobic polymer and a plasticizer, containing therein a bioactive or bioinactive agent, the microparticles containing surface pores, internal pores, or both, but having substantially no internal porosity connecting with the surface.
2. The microparticles of claim 1 , having a surface area ranging from about 0.01 to about 500 m 2 /g.
3. The microparticles of claim 1 , having a total pore volume of about 0.00001 cm 3 /g to about 0.01 cm 3 /g.
4. The microparticles of claim 1 , wherein a hydrophobic polymer comprises a cellulose derivative.
5. The microparticles of claim 1 , wherein a hydrophobic polymer comprises ethyl cellulose.
6. The microparticles of claim 1 , wherein a plasticizer comprises an organic ester, an oil, a glyceride, or a mixture of two or more thereof.
7. The microparticles of claim 1 , wherein a plasticizer comprises an organic ester.
8. The microparticles of claim 1 , being dispersed in a fluid vehicle.
9. The microparticles of claim 1 , being dispersed in a fluid vehicle for topical application.
10. The microparticles of claim 1 , being contained in a solid pharmaceutical dosage form.
11. A composition comprising substantially non-porous polymeric microparticles prepared by
(i) providing a solution comprising a hydrophobic polymer, a plasticizer, and a bioactive agent;
(ii) adding the solution to a hydrophilic liquid to form substantially non-porous polymeric microparticles containing surface pores, internal pores, or both, but having substantially no internal porosity connecting with the surface; and
(iii) dispersing the microparticles in a fluid vehicle.
12. The composition of claim 11 , wherein a hydrophobic polymer comprises a cellulose derivative.
13. The composition of claim 11 , wherein a plasticizer comprises an ester, an oil, a glyceride, or a mixture of two or more thereof.
14. The composition of claim 11 , wherein a plasticizer comprises an ester.
15. The composition of claim 11 , wherein a bioactive agent comprises a drug substance.
16. The composition of claim 11 , wherein a hydrophilic liquid comprises water.
17. The composition of claim 11 , wherein a hydrophilic liquid comprises a water-soluble polymer.
18. The composition of claim 11 , wherein a fluid vehicle comprises a hydrophilic fluid.
19. The composition of claim 11 , wherein a fluid vehicle comprises water.
20. A process for preparing substantially non-porous polymeric microparticles, comprising:
providing a solution comprising a hydrophobic polymer, a bioactive agent, and a plasticizer in an organic solvent;
adding the solution to a hydrophilic liquid, optionally comprising a stabilizer, to form a mixture;
agitating the mixture to form a plurality of droplets of solution suspended in hydrophilic liquid;
separating microparticles from the hydrophilic liquid, and
drying the microparticles at about ambient temperature, wherein the microparticles are substantially non-porous and contain surface pores, internal pores, or both, but have substantially no internal porosity connected with the surface.
21. The microparticles of claim 1 , wherein a bioactive agent comprises tretinoin, tazarotene, terbinafine, erythromycin, fluconazole, benzoyl peroxide, naproxen, adapalene, or any mixtures thereof.
22. The composition of claim 11 , wherein a bioactive agent comprises tretinoin, tazarotene, terbinafine, erythromycin, fluconazole, benzoyl peroxide, naproxen, adapalene, or any mixtures thereof.
23. The process of claim 20 , wherein a bioactive agent comprises tretinoin, tazarotene, terbinafine, erythromycin, fluconazole, benzoyl peroxide, naproxen, adapalene, or any mixtures thereof.
24. Substantially non-porous polymeric microparticles comprising a hydrophobic polymer and a plasticizer, containing therein a bioactive or bioinactive agent, the microparticles containing surface pores, internal pores, or both, but having substantially no internal porosity connecting with the surface, and wherein the total pore volume of the microparticles ranges from about 0.0001 cm 3 /g to about 0.05 cm 3 /g.
25. The microparticles of claim 24 , wherein a bioactive agent comprises tretinoin, tazarotene, terbinafine, erythromycin, fluconazole, benzoyl peroxide, naproxen, adapalene, or any mixtures thereof.